Obigen Pharma Inc. (TPEX:7876)

Obigen Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar 4, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	0.06	0.06	0.06	0.04
Net Debt / Equity Ratio	-0.37	-0.39	-0.43	-0.25
Net Debt / EBITDA Ratio	2.91	3.46	5.20	2.96
Net Debt / FCF Ratio	3.37	3.92	6.54	1.33
Quick Ratio	24.00	22.32	39.29	25.05
Current Ratio	24.54	22.42	42.26	28.78
Return on Equity (ROE)	-	-15.21%	-14.36%	-
Return on Assets (ROA)	-	-9.35%	-8.84%	-
Return on Capital Employed (ROCE)	-18.10%	-16.40%	-12.60%	-14.30%
Buyback Yield / Dilution	-39.47%	-3.45%	-34.82%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.